Patent ID: 9592241
Date: 2017-03-14
CPC Classifications: A61K,A61P

Claim:
1. A silicone-based gel for topical application and treatment of scar tissue, the silicone-based gel comprising: cyclopentasiloxane, polysilicone-11, dimethicone and C30-45 alkyl cetearyl dimethicone crosspolymer; a first active ingredient in a first amount of between approximately 0.1% and approximately 5.0% by weight of the silicone-based gel, the first active ingredient comprising a fluticasone; a second active ingredient in a second amount of between approximately 0.1% and approximately 5.0% by weight of the silicone-based gel, the second active ingredient comprising loratadine; a third active ingredient in a third amount of between approximately 5.0% and approximately 25.0% by weight of the silicone-based gel, the third active ingredient comprising gabapentin; and lidocaine and prilocaine each in an amount of between approximately 1.0% and approximately 7.0% by weight of the silicone-based gel, wherein the topical application of the silicone-based gel allows for transdermal administration of the active ingredients simultaneously.